Business
EU regulator backs use of Novo's Wegovy for obesity-related heart condition - Reuters
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday.
By: Reuters
- Sep 21 2024
- 0
- 0 Views